By Urology Times, 01/15/2022
“…Once widely avoided, testosterone replacement in the setting of prostate cancer has become common practice, according to Wayne J.G. Hellstrom, MD, professor of urology and chief of andrology at Tulane University School of Medicine, in New Orleans, Louisiana…”
Read the entire article: https://www.urologytimes.com/
